Published in Am J Pathol on April 01, 2000
Evaluation of non-formalin tissue fixation for molecular profiling studies. Am J Pathol (2002) 2.38
Laser capture microdissection and two-dimensional polyacrylamide gel electrophoresis: evaluation of tissue preparation and sample limitations. Am J Pathol (2002) 1.10
cDNA arrays and immunohistochemistry identification of CD10/CALLA expression in hepatocellular carcinoma. Am J Pathol (2001) 0.97
The search for an optimal DNA, RNA, and protein detection by in situ hybridization, immunohistochemistry, and solution-based methods. Methods (2010) 0.81
Beyond laser microdissection technology: follow the yellow brick road for cancer research. Am J Cancer Res (2014) 0.81
Prostate cancer: where are we going? Proc (Bayl Univ Med Cent) (2000) 0.75
Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science (1995) 88.48
Serial analysis of gene expression. Science (1995) 60.15
High density synthetic oligonucleotide arrays. Nat Genet (1999) 29.99
PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science (1997) 29.34
Exploring the new world of the genome with DNA microarrays. Nat Genet (1999) 19.05
Use of a cDNA microarray to analyse gene expression patterns in human cancer. Nat Genet (1996) 15.73
Reliable identification of large numbers of candidate SNPs from public EST data. Nat Genet (1999) 13.73
A physical map of 30,000 human genes. Science (1998) 12.43
Laser capture microdissection. Science (1996) 12.21
The I.M.A.G.E. Consortium: an integrated molecular analysis of genomes and their expression. Genomics (1996) 11.71
Drug target validation and identification of secondary drug target effects using DNA microarrays. Nat Med (1998) 9.72
Gene expression profiles in normal and cancer cells. Science (1997) 9.65
New goals for the U.S. Human Genome Project: 1998-2003. Science (1998) 8.30
Generation and analysis of 280,000 human expressed sequence tags. Genome Res (1996) 8.27
Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science (1997) 7.95
Multiplexed biochemical assays with biological chips. Nature (1993) 7.69
The mammalian gene collection. Science (1999) 7.19
Array of hope. Nat Genet (1999) 5.51
Gene expression profiles of laser-captured adjacent neuronal subtypes. Nat Med (1999) 5.12
Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide search. Science (1996) 5.06
Shotgun sequencing of the human genome. Science (1998) 3.97
Laser capture microdissection: molecular analysis of tissue. Science (1997) 3.93
Identification of expressed genes by laser-mediated manipulation of single cells. Nat Biotechnol (1998) 3.46
3,400 new expressed sequence tags identify diversity of transcripts in human brain. Nat Genet (1993) 3.41
The cancer genome anatomy project: building an annotated gene index. Trends Genet (2000) 3.02
Evidence for a prostate cancer susceptibility locus on the X chromosome. Nat Genet (1998) 2.90
New opportunities for uncovering the molecular basis of cancer. Nat Genet (1997) 2.61
Immuno-LCM: laser capture microdissection of immunostained frozen sections for mRNA analysis. Am J Pathol (1999) 2.59
Discovery of three genes specifically expressed in human prostate by expressed sequence tag database analysis. Proc Natl Acad Sci U S A (1998) 1.86
Allelic loss on chromosome 8p12-21 in microdissected prostatic intraepithelial neoplasia. Cancer Res (1995) 1.85
Identification of MEN1 gene mutations in sporadic carcinoid tumors of the lung. Hum Mol Genet (1997) 1.70
Increased gelatinase A (MMP-2) and cathepsin B activity in invasive tumor regions of human colon cancer samples. Am J Pathol (1994) 1.36
High expression of a specific T-cell receptor gamma transcript in epithelial cells of the prostate. Proc Natl Acad Sci U S A (1999) 1.34
The genetics of cancer--a 3D model. Nat Genet (1999) 1.26
Construction of a representative cDNA library from prostatic intraepithelial neoplasia. Cancer Res (1996) 1.23
Loss of heterozygosity of chromosome 8 microsatellite loci implicates a candidate tumor suppressor gene between the loci D8S87 and D8S133 in human prostate cancer. Cancer Res (1994) 1.19
Development of a prostate cDNA microarray and statistical gene expression analysis package. Mol Carcinog (2000) 1.16
Loss of chromosome arm 8p loci in prostate cancer: mapping by quantitative allelic imbalance. Genes Chromosomes Cancer (1994) 1.15
An improved method for construction of directionally cloned cDNA libraries from microdissected cells. Cancer Res (1998) 1.13
A catalog of cancer genes at the click of a mouse. Science (1997) 1.04
Review of allelic loss and gain in prostate cancer. World J Urol (1996) 1.03
Identification of a novel transcript up-regulated in a clinically aggressive prostate carcinoma. Urology (1997) 0.97
Immunotoxins that target an oncogenic mutant epidermal growth factor receptor expressed in human tumors. Clin Cancer Res (1995) 0.97
Localization of the multiple endocrine neoplasia type I (MEN1) gene based on tumor loss of heterozygosity analysis. Cancer Res (1997) 0.96
Entering the postgenome era. Science (1995) 0.92
Molecular advances in prostate cancer. Curr Opin Oncol (1997) 0.90
Pattern recognition and arrays: the times are a-changing. Am J Pathol (1999) 0.89
Haplotype analysis defines a minimal interval for the multiple endocrine neoplasia type 1 (MEN1) gene. Cancer Res (1997) 0.85
cDNA sequencing and analysis of POV1 (PB39): a novel gene up-regulated in prostate cancer. Genomics (1998) 0.80
11q13 allelotype analysis in 27 northern American MEN1 kindreds identifies two distinct founder chromosomes. Mol Genet Metab (1998) 0.78
Initial sequencing and analysis of the human genome. Nature (2001) 212.86
A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms. Nature (2001) 42.18
dbEST--database for "expressed sequence tags". Nat Genet (1993) 41.10
Database resources of the National Center for Biotechnology Information. Nucleic Acids Res (2000) 34.79
Ligand: a versatile computerized approach for characterization of ligand-binding systems. Anal Biochem (1980) 28.03
Introducing RefSeq and LocusLink: curated human genome resources at the NCBI. Trends Genet (2000) 19.33
Database resources of the National Center for Biotechnology Information. Nucleic Acids Res (2001) 19.13
Rapid redistribution of Golgi proteins into the ER in cells treated with brefeldin A: evidence for membrane cycling from Golgi to ER. Cell (1989) 13.41
Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves. Am J Physiol (1978) 13.02
A physical map of 30,000 human genes. Science (1998) 12.43
A physical map of the human genome. Nature (2001) 12.39
Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy (2008) 12.35
Laser capture microdissection. Science (1996) 12.21
Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci U S A (1986) 12.14
The I.M.A.G.E. Consortium: an integrated molecular analysis of genomes and their expression. Genomics (1996) 11.71
Integration of cytogenetic landmarks into the draft sequence of the human genome. Nature (2001) 10.96
SAGEmap: a public gene expression resource. Genome Res (2000) 10.41
Rapid gene mapping in Caenorhabditis elegans using a high density polymorphism map. Nat Genet (2001) 9.54
Microtubule-dependent retrograde transport of proteins into the ER in the presence of brefeldin A suggests an ER recycling pathway. Cell (1990) 9.19
A public database for gene expression in human cancers. Cancer Res (1999) 8.81
NCBI's LocusLink and RefSeq. Nucleic Acids Res (2000) 8.63
Data management and analysis for gene expression arrays. Nat Genet (1998) 8.60
Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc Natl Acad Sci U S A (1994) 8.47
Generation and analysis of 280,000 human expressed sequence tags. Genome Res (1996) 8.27
Nonuniform recombination within the human beta-globin gene cluster. Am J Hum Genet (1984) 7.97
Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science (1997) 7.95
Genomics. Genome project standards in a new era of sequencing. Science (2009) 7.72
Rapid cDNA sequencing (expressed sequence tags) from a directionally cloned human infant brain cDNA library. Nat Genet (1993) 7.38
A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone. N Engl J Med (1987) 7.33
The mammalian gene collection. Science (1999) 7.19
High throughput fingerprint analysis of large-insert clones. Genome Res (1997) 6.91
Isolation and characterization of type IV procollagen, laminin, and heparan sulfate proteoglycan from the EHS sarcoma. Biochemistry (1982) 6.87
Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas. Nat Genet (1997) 6.83
Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy. N Engl J Med (1995) 6.77
Niemann-Pick C1 disease gene: homology to mediators of cholesterol homeostasis. Science (1997) 6.66
Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu Rev Cell Biol (1993) 6.53
Biosynthesis, cleavage, and degradation of the human immunodeficiency virus 1 envelope glycoprotein gp160. Proc Natl Acad Sci U S A (1988) 6.33
Brefeldin A's effects on endosomes, lysosomes, and the TGN suggest a general mechanism for regulating organelle structure and membrane traffic. Cell (1991) 6.30
Normalization and subtraction: two approaches to facilitate gene discovery. Genome Res (1996) 6.20
Improving physicians' interviewing skills and reducing patients' emotional distress. A randomized clinical trial. Arch Intern Med (1995) 6.15
Analysis of human transcriptomes. Nat Genet (1999) 6.14
Making effective use of human genomic sequence data. Trends Genet (1999) 6.12
Brefeldin A inhibits Golgi membrane-catalysed exchange of guanine nucleotide onto ARF protein. Nature (1992) 6.11
ESTablishing a human transcript map. Nat Genet (1995) 5.89
Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature (1980) 5.84
Receptor-mediated endocytosis of transferrin and the uptake of fe in K562 cells: identification of a nonlysosomal acidic compartment. Proc Natl Acad Sci U S A (1982) 5.74
Evidence for a novel gene associated with low tumor metastatic potential. J Natl Cancer Inst (1988) 5.42
A genetic mapping system in Caenorhabditis elegans based on polymorphic sequence-tagged sites. Genetics (1992) 5.37
Association of the fyn protein-tyrosine kinase with the T-cell antigen receptor. Proc Natl Acad Sci U S A (1990) 5.35
A mutant affecting the heavy chain of myosin in Caenorhabditis elegans. J Mol Biol (1974) 5.33
Tumor invasion and metastases--role of the extracellular matrix: Rhoads Memorial Award lecture. Cancer Res (1986) 5.05
Mutants with altered muscle structure of Caenorhabditis elegans. Dev Biol (1980) 5.03
Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation. N Engl J Med (2000) 4.99
Iron-responsive elements: regulatory RNA sequences that control mRNA levels and translation. Science (1988) 4.86
A systematic, high-resolution linkage of the cytogenetic and physical maps of the human genome. Nat Genet (2000) 4.78
Binding of apotransferrin to K562 cells: explanation of the transferrin cycle. Proc Natl Acad Sci U S A (1983) 4.68
A permease-oxidase complex involved in high-affinity iron uptake in yeast. Science (1996) 4.60
Degradation from the endoplasmic reticulum: disposing of newly synthesized proteins. Cell (1988) 4.42
Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front. Oncogene (2001) 4.40
A novel di-leucine motif and a tyrosine-based motif independently mediate lysosomal targeting and endocytosis of CD3 chains. Cell (1992) 4.39
Binding of a cytosolic protein to the iron-responsive element of human ferritin messenger RNA. Science (1988) 4.35
Crx, a novel Otx-like paired-homeodomain protein, binds to and transactivates photoreceptor cell-specific genes. Neuron (1997) 4.33
Gene discovery in dbEST. Science (1994) 4.32
Novel interleukin-2 receptor subunit detected by cross-linking under high-affinity conditions. Science (1986) 4.30
A novel randomized iterative strategy for aligning multiple protein sequences. Comput Appl Biosci (1991) 4.24
The AZFc region of the Y chromosome features massive palindromes and uniform recurrent deletions in infertile men. Nat Genet (2001) 4.24
Inhibition of transcription elongation by the VHL tumor suppressor protein. Science (1995) 4.23
Surveying Saccharomyces genomes to identify functional elements by comparative DNA sequence analysis. Genome Res (2001) 4.22
ADP-ribosylation factor, a small GTP-binding protein, is required for binding of the coatomer protein beta-COP to Golgi membranes. Proc Natl Acad Sci U S A (1992) 4.22
Identification of the components of the murine T cell antigen receptor complex. Cell (1985) 4.20
Identification of the iron-responsive element for the translational regulation of human ferritin mRNA. Science (1987) 4.20
Brefeldin A, a drug that blocks secretion, prevents the assembly of non-clathrin-coated buds on Golgi cisternae. Cell (1991) 4.17
Association of genetic variation of the transforming growth factor-alpha gene with cleft lip and palate. Am J Hum Genet (1989) 4.13
A second informational suppressor, SUP-7 X, in Caenorhabditis elegans. Genetics (1981) 4.04
A comprehensive human linkage map with centimorgan density. Cooperative Human Linkage Center (CHLC). Science (1994) 4.02
Quantitative relationships of intravascular tumor cells, tumor vessels, and pulmonary metastases following tumor implantation. Cancer Res (1974) 3.96
Laser capture microdissection: molecular analysis of tissue. Science (1997) 3.93
Dissociation of a 110-kD peripheral membrane protein from the Golgi apparatus is an early event in brefeldin A action. J Cell Biol (1990) 3.90
Post-transcriptional regulation of vascular endothelial growth factor mRNA by the product of the VHL tumor suppressor gene. Proc Natl Acad Sci U S A (1996) 3.88